1. Home
  2. HQI vs GBIO Comparison

HQI vs GBIO Comparison

Compare HQI & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HireQuest Inc. (DE)

HQI

HireQuest Inc. (DE)

N/A

Current Price

$10.68

Market Cap

111.0M

ML Signal

N/A

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.45

Market Cap

36.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HQI
GBIO
Founded
2002
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.0M
36.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
HQI
GBIO
Price
$10.68
$5.45
Analyst Decision
Buy
Buy
Analyst Count
1
5
Target Price
$13.00
$8.88
AVG Volume (30 Days)
53.9K
69.2K
Earning Date
11-06-2025
11-05-2025
Dividend Yield
2.24%
N/A
EPS Growth
412.84
N/A
EPS
0.50
N/A
Revenue
$31,691,000.00
$15,270,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$20.59
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.38
$3.00
52 Week High
$15.75
$12.40

Technical Indicators

Market Signals
Indicator
HQI
GBIO
Relative Strength Index (RSI) 68.34 49.21
Support Level $9.78 $5.40
Resistance Level $10.77 $5.77
Average True Range (ATR) 0.68 0.22
MACD 0.26 0.02
Stochastic Oscillator 85.49 43.85

Price Performance

Historical Comparison
HQI
GBIO

About HQI HireQuest Inc. (DE)

HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: